Latest Business and People News

People

Actinium Pharmaceuticals, a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, has appointed Gregory Bergonio, M.S.H.S., to the position of Director of Clinical Operations.

SCORR Marketing announced the promotions of Lauren Naughton to business development director, Ashlee Swanson to copy director, Marc Bacon to lead developer and Holli Kroeker to PR and media manager.

Holli Kroeker

Marc Bacon

Ashlee Swanson

Lauren Naughton

EFPIA will be headed ad interim by Eric Cornut. Currently an independent consultant, Cornut has held roles of increasing responsibility, including Head of Europe, Chief Commercial Officer, and most recently Chief Ethics, Compliance and Policy Officer at Novartis.

Clinical Network Services, an integrated service group focused on clinical product development, has announced the appointment of Martin Moxham as Principal Regulatory Consultant for Europe.

Mark Heinold

TrialScope’s Board of Directors have appointed Mark Heinold as chief executive officer. Heinold has over 20 years of experience in the healthcare industry. Most recently, he served as chief executive officer for Physician's Desk Reference (PDR). He also spent over 10 years at Novartis Pharmaceuticals Corporation where he held various executive leadership positions in marketing, sales, and operations.

Greenphire has appointed Dave Espenshade to the role of Vice President, CRO Partnerships.

The 2017 term the Regulatory Affairs Professional Society (RAPS) board officers and directors follows:

Chairman of the Board

• Todd Chermak, RPh, PhD, divisional vice president of Innovation & Development, Abbott Established Pharmaceuticals

President

• Susumu Nozawa, RAC, FRAPS, director of corporate regulatory affairs for the Japan region, BD

President-Elect

• Don Boyer, BSc, RAC, FRAPS, owner and president, BOYER@RegulatorySolns

Treasurer

• Salma Michor, PhD, MSc, MBA, CMgr, RAC, founder and CEO of Michor Consulting e.U

Directors

• Gert Bos, PhD, FRAPS, executive director and partner, Qserve Group

• Paul Brooks, executive director, RAPS

• Glenn N. Byrd, MBA, RAC, senior director, promotional regulatory affairs, AstraZeneca

• David E. Chadwick, PhD, RAC, FRAPS, director of regulatory affairs and regulatory science, Cook Inc.

• Raina Dauria, MS, RAC, vice president of regulatory affairs, Ethicon Biosurgery

• Jethro Ekuta, DVM, PhD, RAC, FRAPS, vice president and head of regulatory affairs North America, Johnson & Johnson Consumer Inc.

• Laila Gurney, MSc, RAC, executive, regulatory affairs, GE Healthcare

• Michael Morton, RAC, FRAPS, vice president for corporate regulatory affairs, Medtronic Inc.

• Judith Smith, MS, MT (ASCP), vice president of in vitro diagnostics and quality within Precision for Medicine’s translational and regulatory sciences practice

• Edward Tabor, MD, vice president, regulatory affairs North America, Fresenius Kabi

Recognition

Exco InTouch was recognized for the third year running as an honoree in the Journal of mHealth’s Global Digital Health 100.

Business News

CRF Health will open a new office location and workforce in Romania to support CRF Health’s existing sites at locations across the US, UK and Finland.

CROS NT has opened new office in Bangalore, India. The Bangalore office is the fourth global office established by CROS NT in the last six years, including branches in Italy, Germany, the United Kingdom and the United States.

Exco InTouch (an ERT company) has formally received EU-U.S. Privacy Shield Framework Self-Certification status by the U.S. Department of Commerce’s International Trade Administration (ITA). The designation certifies that Exco InTouch’s practices meet or exceed the data privacy and security principles outlined by U.S. Department of Commerce and European Commission.